Posts Tagged ‘health’



November 28th, 2017

The Transfer of Pandemic Risk from the Public Sector

Posted at 1:00 AM ET

Here we review recent GC Capital Ideas posts on pandemic risk and the role of the capital markets to transfer risk from the public sector.

Continue reading…

November 20th, 2017

Understanding Systemic Cyber Risk; Insights Through Pandemic Behavior

Posted at 1:00 AM ET

platt-jeremybhamory-crop-smshafer-chris-sm1Jeremy S. Platt, U.S. Cyber Specialty Practice Leader, Guy Carpenter; Bruce Hamory M.D., Chief Medical Officer for Health and Life Sciences at Oliver Wyman Consulting and Christopher Shafer, Assistant Vice President, Guy Carpenter

Contact

  • Jeremy S. Platt is Managing Director and U.S. Cyber Specialty Practice Leader at Guy Carpenter; Bruce Hamory, M.D. is a Partner and Chief Medical Officer for Health and Life Sciences at Oliver Wyman Consulting. They represent operating companies of Marsh & McLennan Companies.

Continue reading…

October 17th, 2017

Understanding Systemic Cyber Risk; Insights Through Pandemic Behavior - GC@PCI Commentary

Posted at 11:30 AM ET

platt-jeremybhamory-crop-smshafer-chris-sm1

Jeremy S. Platt, U.S. Cyber Specialty Practice Leader, Guy Carpenter; Bruce Hamory M.D., Chief Medical Officer for Health and Life Sciences at Oliver Wyman Consulting and Christopher Shafer, Assistant Vice President, Guy Carpenter

Contact

  • Jeremy S. Platt is Managing Director and U.S. Cyber Specialty Practice Leader at Guy Carpenter; Bruce Hamory, M.D. is a Partner and Chief Medical Officer for Health and Life Sciences at Oliver Wyman Consulting. They represent operating companies of Marsh & McLennan Companies.

Continue reading…

June 28th, 2017

GC Securities* Supports First Ever World Bank Catastrophe Bonds and Catastrophe-linked Swaps to Combat Infectious Disease

Posted at 9:31 PM ET

GC Securities, a division of MMC Securities LLC, a U.S. registered broker-dealer and member FINRA/NFA/SIPC, participated in today’s pricing of bonds and catastrophe-linked swaps supporting pandemic risk. Part of an innovative new public-private partnership aimed at improving global resiliency and health security, the mechanism provides surge funding to developing countries facing a possible pandemic outbreak. GC Securities served as co-manager of the bonds and joint arranger of the swaps. Data from the World Health Organization (WHO) was used by AIR Worldwide to provide expert risk modeling.

Continue reading…

February 28th, 2017

Coming Together for Healthcare Reform

Posted at 1:00 AM ET

Approximately 177 million Americans receive healthcare coverage from their employers, and in 2015, U.S. employers collectively spent USD 668 billion on health benefits, outpacing federal spending on Medicare.

Continue reading…

September 27th, 2016

Longevity Risk

Posted at 1:00 AM ET

The impacts to society from changes in longevity and life expectancy will be wide-ranging and incredibly difficult issues to grapple with. A 2012 International Monetary Fund (IMF) study revealed that if individuals lived three years longer than expected the cost of aging could increase by 50 percent. This translates to 50 percent of 2010 gross domestic product (GDP) in advanced economies and 25 percent of 2010 GDP in emerging economies. Globally that amounts to tens of trillions of US dollars. The United Nations expects the aggregate expenses of the elderly will double over the period between 2010 and 2050. TheĀ figure below shows the projected trend of rising life expectancy to continue in all regions of the globe regardless of economic advancement.

Continue reading…

August 23rd, 2016

Emerging Risks: Modeling Considerations Moving Forward: Part I

Posted at 1:00 AM ET

william-garland-smWill Garland, Managing Director

Contact

Technological progress is accelerating at a rapid pace and with it are the risks and opportunities that accompany those changes in many different segments of our economy:

Continue reading…

August 16th, 2016

Advancing Technologies Raise Issues for (Re)insurers

Posted at 1:00 AM ET

Here we review GC Capital Ideas posts on advancing technologies that are creating new opportunities and new risks for (re)insurers.

Continue reading…

August 1st, 2016

New Economics Are Creating New Medicine, Part II

Posted at 1:00 AM ET

Predictive analytics or predictive medicine uses patient-specific data and enables a more customized, precise approach for patient-specific treatment. With the insight this provides, biotechnology, pharmaceutical and medical device companies can partner to provide better care, improve compliance, lower readmission rates and drive improved outcomes. This can lower unnecessary and ineffective treatments and decrease the overall cost of care. However, taken to an extreme scenario, life science companies could invest in developing much more specific treatments for very small cohorts of affected patients. These focused therapies could be extremely expensive and would be wildly impractical without the intersection of new technology and new economics.

Continue reading…

July 28th, 2016

New Economics Are Creating New Medicine, Part I

Posted at 1:00 AM ET

Through the Affordable Care Act, many measures are being implemented that are expected to have a positive impact on bending the healthcare cost curve downward in the long term. However, the same act removed annual and lifetime limits for medical insurance claims. As a result, the maximum potential loss from a single individual is a new frontier of risk, with new heights being reached each year. This is both a frequency and severity issue.

Continue reading…